A mouse model for donor lymphocyte infusion reveals that a single immunodominant minor H antigen is responsible for the beneficial effects of donor T lymphocytes against host leukemia. Separating the good from the bad could mean the end of graft-versus-host disease in bone marrow transplants. (pages 789–794)
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fontaine, P. et al. Adoptive tranfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nature Med. 7, 789–794 (2001).
Apperley, J.F. et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant. 1, 53–66 (1986).
Dazzi, F., Szydlo, R.M. & Goldman, J.M. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand. Exp. Hematol. 27, 1477–1486 (1999).
Goulmy, E. et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334, 281–285 (1996).
Barrett, A.J. et al. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplant. 21, 543–551 (1998).
Dazzi, F. et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 95, 67–71 (2000).
Gallucci, S. & Matzinger, P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114–119 (2001).
Krenger, W., Hill, G.R. & Ferrara, J.L. Cytokine cascades in acute graft-versus-host disease. Transplantation 64, 553–558 (1997).
Mutis, T. et al. Feasibility of immunotherapy of relapsed leukemia with ex vivo- generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 93, 2336–2341 (1999).
Lehmann, P.V., Forsthuber, T., Miller, A. & Sercarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155–157 (1992).
Simpson, E. & Roopenian, D. Minor histocompatibility antigens. Curr. Opin. Immunol. 9, 655–661 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dazzi, F., Simpson, E. & Goldman, J. Minor antigen solves major problem. Nat Med 7, 769–770 (2001). https://doi.org/10.1038/89874
Issue Date:
DOI: https://doi.org/10.1038/89874
This article is cited by
-
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction
Nature Immunology (2003)